Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2009
08/19/2009EP2089017A2 Methods of treating neuropathic pain by modulation of glycogenolysis or glycolysis pathways
08/19/2009EP2089016A2 Method for treatment of macular degeneration
08/19/2009EP2089015A2 Methods for treating disruptive behavior disorders
08/19/2009EP2089013A1 Acetaminophen / ibuprofen combinations
08/19/2009EP2089012A2 Polymorphs of n²-(1,1'- biphenyl- 4-ylcarbonyl)-n¹-[2-(4-fluorophenyl)-1,1-dimethylethyl]-l-alpha -glutamine
08/19/2009EP2089011A1 Treatment of pervasive developmental disorders
08/19/2009EP2089010A1 Rapid release mini-tablets provide analgesia in laboratory animals
08/19/2009EP2089009A2 Use of lxr agonists for the treatment of osteoarthritis
08/19/2009EP2089008A2 Formulations for delivery via pressurised metered dose inhalers comprising an essential oil as suspension stabiliser
08/19/2009EP2089007A2 Transdermal delivery of ketoprofen polar derivatives
08/19/2009EP2089006A2 Medicament with controlled release containing galanthamine
08/19/2009EP2089005A2 Layered pharmaceutical formulations comprising an intermediate rapidly dissolving layer
08/19/2009EP2089003A1 Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
08/19/2009EP2089002A1 Phenylalkyl carbamate compositions
08/19/2009EP2088999A1 Pharmaceutical composition comprising an active ingredient which neutralizes and/or binds gastric acid, such as an alginic acid derivative
08/19/2009EP2088998A2 Unit dosage package and methods for administering weight loss medications
08/19/2009EP2088996A1 Liquid pharmaceutical compositions comprising a bisphosphonate compound
08/19/2009EP2088863A2 Tyrosine kinase inhibitors as anti-kinetolastid and anti-apicomplexan agents
08/19/2009EP2088861A2 Benzimidazole compounds
08/19/2009EP2088860A1 Chemokine receptor binding compounds
08/19/2009EP2035394B1 2-pyrazinecarboxamide derivatives
08/19/2009EP2004197A4 Light activated antiviral materials and devices and methods for decontaminating virus infected environments
08/19/2009EP1999113B1 Substituted 1-amino-4-phenyl-dihydroisoquinolines, method for the production thereof, use thereof as a medicament, and medicaments containing them
08/19/2009EP1971369B1 Combination of r,r-glycopyrrolate, rolipram and budesonide for the treatment of inflammatory diseases
08/19/2009EP1940877A4 Modified biodegradable polymers, preparation and use thereof for making biomaterials and dressings
08/19/2009EP1937679B1 Preparation and use of tetrahydropyrrolo [3, 2-c] pyridin-4-one derivatives for treatment of obesity, psychiatric and neurological disorders
08/19/2009EP1915144A4 Method to reduce oxidative damage and improve mitochondrial efficiency
08/19/2009EP1871395A4 Garlic extract and chitosan compositions, and uses thereof
08/19/2009EP1863499B1 Method for inhibiting and/or treating vaginal infection
08/19/2009EP1853232B1 Stable crystalline form of bifeprunox mesylate, dosage forms thereof adn methods for using them
08/19/2009EP1846379B1 Antidiabetic bicyclic compounds
08/19/2009EP1838304B1 Heterocyclic aspartyl protease inhibitors
08/19/2009EP1814555B1 S-mirtazapine for the treatment of hot flush
08/19/2009EP1791837B1 Substituted hydantoins for the treatment of cancer
08/19/2009EP1753431B1 Pharmaceutical compositions comprising zd6474
08/19/2009EP1740585B1 Enantiomer-pure hexahydropyrrolocyclopentapyridine derivatives
08/19/2009EP1740225A4 Contrast agents for myocardial perfusion imaging
08/19/2009EP1735337B1 Method of producing highly pure teicoplanin
08/19/2009EP1718617B1 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
08/19/2009EP1696923B1 Nicotine delivery product and method for producing
08/19/2009EP1689712B1 4-phenylpiperidine derivatives as renin inhibitors
08/19/2009EP1685123B1 Substituted dihydroquinazolines ii
08/19/2009EP1677664A4 Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
08/19/2009EP1641460B1 Stable 5, 10-methylene-tetrahydrofolate pharmaceutical compounds
08/19/2009EP1641453B1 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent
08/19/2009EP1635824B1 5-membered heterocycle-based p-38 inhibitors
08/19/2009EP1633335A4 Improved absorption of fat-soluble nutrients
08/19/2009EP1615645B1 A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for the preparation thereof
08/19/2009EP1606293B1 Cephalosporin in crystalline form
08/19/2009EP1591123B1 Uses of naringenin, naringin and salts thereof as expectorants in the treatment of cough, and compositions thereof
08/19/2009EP1590334B1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
08/19/2009EP1566182A4 Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure
08/19/2009EP1497467B1 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof
08/19/2009EP1485393B1 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
08/19/2009EP1480653B1 Ribavirin syrup formulations
08/19/2009EP1478339B9 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
08/19/2009EP1465593B1 Solid orally-dispersible pharmaceutical formulation
08/19/2009EP1463529B1 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy
08/19/2009EP1463498B1 pharmaceutical COMPOSITION comprising a catechin, ascorbic acid, proline and lysine FOR THE TREATMENT OF NEOPLASTIC DISEASES
08/19/2009EP1436286B1 Fumagillol derivatives and preparing method thereof
08/19/2009EP1420743B1 Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function
08/19/2009EP1414466B1 Combinations for the treatment of inflammatory disorders
08/19/2009EP1351677A4 Method for treating cancer
08/19/2009EP1348706B1 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
08/19/2009EP1343509B1 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
08/19/2009EP1287349B1 Method and apparatus for monitoring anti-platelet agents
08/19/2009EP1280566B1 Growth factor modified protein matrices for tissue engineering
08/19/2009EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
08/19/2009EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
08/19/2009EP1187918B9 Tek antagonists
08/19/2009EP1183240B1 Beta2-adrenoceptor agonists
08/19/2009EP1137639B1 Control of arthropods in animals
08/19/2009EP1119356B1 Radiolabeled neurokinin-1 receptor antagonists
08/19/2009EP0971740B1 Fibronectin binding protein derived peptides which do not bind to fibronectin, antibodies thereto, and therapeutic uses
08/19/2009CN101511993A Retinoid compounds and their use
08/19/2009CN101511860A SMAC peptidomimetics useful as IAP inhibitors
08/19/2009CN101511857A 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one) and pharmaceutical preparations containing the same
08/19/2009CN101511855A New macrolides useful against inflammatory and allergic disseases
08/19/2009CN101511852A Synthesis of diethyl{ i5'' (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs
08/19/2009CN101511845A Spiro antibiotic derivatives
08/19/2009CN101511842A Dihydrofuro pyrimidines as AKT protein kinase inhibitors
08/19/2009CN101511841A Tetrahydrofuro [3, 2 -b] pyrrol-3-ones as cathepsin K inhibitors
08/19/2009CN101511840A Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
08/19/2009CN101511838A A pyrrolopyrazin as SYK-kinase inhibitor
08/19/2009CN101511837A Pyrrolopyrimidines for pharmaceutical compositions
08/19/2009CN101511836A Fused pyrimido compounds
08/19/2009CN101511835A 吡咯并三嗪激酶抑制剂 Pyrrolotriazine kinase inhibitors
08/19/2009CN101511833A 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulene derivatives as orexin receptor antagonists
08/19/2009CN101511832A Fused heterocyclic inhibitors of D-amino acid oxidase
08/19/2009CN101511831A Adenosine derivatives as A2A receptor agonists.
08/19/2009CN101511828A Heteroaryl derivatives as protein kinase inhibitors
08/19/2009CN101511827A Pyridin-4-yl derivatives as immunomodulating agents
08/19/2009CN101511826A Preparation and purification of mupirocin calcium
08/19/2009CN101511825A Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (GSK3)
08/19/2009CN101511824A Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (GSK3)
08/19/2009CN101511823A Multifunctional bioactive compounds
08/19/2009CN101511822A Modulators of chemokine receptor activity, crystalline forms and process
08/19/2009CN101511819A N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
08/19/2009CN101511817A Pyridine- and quinoline-pyrimidine-derivatives
08/19/2009CN101511816A An aminoisoquinoline thrombin inhibitor with improved bioavailability
1 ... 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 ... 7860